Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In vitro assessment of the risk of ABCB1-mediated drug-drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell lines.
Mahieu G, Sennesael AL, Pochet L, Haufroid V, Van Bambeke F, Spinewine A, Elens L. Mahieu G, et al. Among authors: spinewine a. Res Pract Thromb Haemost. 2024 Jul 22;8(5):102521. doi: 10.1016/j.rpth.2024.102521. eCollection 2024 Jul. Res Pract Thromb Haemost. 2024. PMID: 39228433 Free PMC article.
Development of the Guide to Disseminating Research (GuiDiR): A consolidated framework.
Scott S, Atkins B, D'Costa T, Rendle C, Murphy K, Taylor D, Smith C, Kellar I, Briggs A, Griffiths A, Hornak R, Spinewine A, Thompson W, Tsuyuki R, Bhattacharya D. Scott S, et al. Among authors: spinewine a. Res Social Adm Pharm. 2024 Nov;20(11):1047-1057. doi: 10.1016/j.sapharm.2024.08.001. Epub 2024 Aug 22. Res Social Adm Pharm. 2024. PMID: 39183076 Free article.
Patient and public involvement in pragmatic trials: online survey of corresponding authors of published trials.
Vanderhout S, Nevins P, Nicholls SG, Macarthur C, Brehaut JC, Potter BK, Gillies K, Goulao B, Smith M, Hilderley A, Carroll K, Spinewine A, Weijer C, Fergusson DA, Taljaard M. Vanderhout S, et al. Among authors: spinewine a. CMAJ Open. 2023 Sep 19;11(5):E826-E837. doi: 10.9778/cmajo.20220198. Print 2023 Sep-Oct. CMAJ Open. 2023. PMID: 37726115 Free PMC article.
Measuring Quality of Life in Deprescribing Trials: A Scoping Review.
Thompson W, Lundby C, Bleik A, Waring H, Hong JA, Xi C, Hughes C, Salzwedel DM, McDonald EG, Pruskowski J, Scott S, Spinewine A, Kutner JS, Graabæk T, Elmi S, Moriarty F. Thompson W, et al. Among authors: spinewine a. Drugs Aging. 2024 May;41(5):379-397. doi: 10.1007/s40266-024-01113-0. Epub 2024 May 6. Drugs Aging. 2024. PMID: 38709466 Review.
Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks.
McDonald EG, Lundby C, Thompson W, Boyd C, Farrell B, Gagnon C, Herbin J, Khuong N, Moriarty F, Pierson T, Scott S, Scott IA, Silvius J, Spinewine A, Steinman MA, Tannenbaum C, Trimble J, Turner JP, Reeve E. McDonald EG, et al. Among authors: spinewine a. Expert Rev Clin Pharmacol. 2024 May-Jun;17(5-6):433-440. doi: 10.1080/17512433.2024.2355270. Epub 2024 May 20. Expert Rev Clin Pharmacol. 2024. PMID: 38739460 Free article. Review.
133 results